search
Back to results

Effectiveness of autoHYpnosis in the Prevention of Anxiety During Radiotherapy of Head and Neck Tumors (HYMACO) (HYMACO)

Primary Purpose

Head and Neck Tumors

Status
Recruiting
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Standard care
Autohypnosis
Musicotherapy
Sponsored by
Institut de Cancérologie de Lorraine
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Head and Neck Tumors focused on measuring Autohypnosis, Anxiety, 5 points Mask, Radiotherapy, Anchoring

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age > or =18
  • Patient to receive radiotherapy for a tumor of the head and neck, with a compression mask
  • Patient who obtained a score equal to or greater than 56 on the STAI form Y-A questionnaire during the consultation with the radiotherapist before starting treatment
  • Patient capable and willing to follow all study procedures in accordance with the protocol
  • Patient who understood the study and gave informed consent
  • Patient affiliated to a social security system

Exclusion Criteria:

  • Contraindication to hypnosis: psychosis, schizophrenia
  • Non-French speaking patient
  • Significant hearing loss
  • Pregnant woman, likely to be, or breastfeeding
  • Persons deprived of their liberty or under guardianship (including guardianship)
  • Inability to undergo medical monitoring of the trial for geographical, social or psychological reasons
  • Patient who has already received radiotherapy to the head or neck with a compression mask

Sites / Locations

  • Institut de Cancérologie de Lorraine
  • Institut de Cancérologie de LorraineRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Active Comparator

Active Comparator

Active Comparator

Arm Label

ARM A : standard care

ARM B : standard care + Autohypnosis

ARM C : standard care + Musicotherapy

Arm Description

standard care : Patient undergoing radiotherapy for head and neck tumor with a compression mask, and assessed as anxious about wearing this mask will have standard care

In addition to the standard care, the patient will be called to learn autohypnosis during a specific consultation, with a radiotherapy manipulator trained to learn this technic. The patient will use this technic during the centering scanner and the first 5 radiotherapy sessions

In addition to the standard care, the patient will choose the music he want to listen from a music database (3 specific moods). The chosen music will be broadcast to the patient via a hi-fi system present in the treatment room during the centering scanner and for the first 5 radiotherapy sessions

Outcomes

Primary Outcome Measures

Anxiety
Anxiety will be assessed by the maximum value obtained on the STAI form Y-A questionnaire (state anxiety) on the following 3 measurements: on the centering scanner, at the first and 5th radiotherapy session.

Secondary Outcome Measures

Anxiety
Anxiety will also be assessed by a digital rating scale (0 to 10), in the centering or radiotherapy scanner room, just before making the mask before the centering scan and before fitting the mask before each of the first five radiotherapy sessions
Conduct of radiotherapy session
The good conduct of the centering scanner and radiotherapy session is determined by: no interruption of the session the absence of vocal intervention by the manipulator during the session
Time required by the hypnopractor for the hypnosis session
The duration of the conditioning hypnosis session will be collected by the hypnopractor manipulator
Receptivity of patients to hypnosis
Corresponds to the time difference in minutes between the actual time of making and wearing the compression mask for the centering scanner and wearing a compression mask for the first 5 radiotherapy sessions and the time estimated by the patient
Assessment of the patient's feelings
The patient's feelings will be evaluate a questionnaire composed of 5 questions already used in a previous study
Hypnopractic manipulator's satisfaction with the ease of performing the conditioning hypnosis
Assesing by the hypnopractor manipulator at the end of the session using a digital rating scale (0 to 10).

Full Information

First Posted
December 7, 2020
Last Updated
July 27, 2023
Sponsor
Institut de Cancérologie de Lorraine
search

1. Study Identification

Unique Protocol Identification Number
NCT04671485
Brief Title
Effectiveness of autoHYpnosis in the Prevention of Anxiety During Radiotherapy of Head and Neck Tumors (HYMACO)
Acronym
HYMACO
Official Title
Randomized, Comparative Pilot Study Evaluating the Effectiveness of autoHYpnosis by Anchoring in the Prevention of Anxiety Related to Wearing the Mask for Radiotherapy of Head and Neck Tumors
Study Type
Interventional

2. Study Status

Record Verification Date
July 2023
Overall Recruitment Status
Recruiting
Study Start Date
December 16, 2020 (Actual)
Primary Completion Date
January 2025 (Anticipated)
Study Completion Date
January 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Institut de Cancérologie de Lorraine

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
HYMACO is a monocentric, randomized comparative pilot study with a total duration of 25 months. The purpose of this study is to evaluate the effectiveness of autoHYpnosis by anchoring in the prevention of anxiety related to wearing the mask for radiotherapy of head and neck tumors. 60 patients will be randomized into 3 arms ARM A : Standard care ARM B : Autohypnosis ARM C : Musicotherapy This study is carried out during the first 5 radiotherapy sessions because this is decisive for the good progress of subsequent sessions

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Head and Neck Tumors
Keywords
Autohypnosis, Anxiety, 5 points Mask, Radiotherapy, Anchoring

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
60 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
ARM A : standard care
Arm Type
Active Comparator
Arm Description
standard care : Patient undergoing radiotherapy for head and neck tumor with a compression mask, and assessed as anxious about wearing this mask will have standard care
Arm Title
ARM B : standard care + Autohypnosis
Arm Type
Active Comparator
Arm Description
In addition to the standard care, the patient will be called to learn autohypnosis during a specific consultation, with a radiotherapy manipulator trained to learn this technic. The patient will use this technic during the centering scanner and the first 5 radiotherapy sessions
Arm Title
ARM C : standard care + Musicotherapy
Arm Type
Active Comparator
Arm Description
In addition to the standard care, the patient will choose the music he want to listen from a music database (3 specific moods). The chosen music will be broadcast to the patient via a hi-fi system present in the treatment room during the centering scanner and for the first 5 radiotherapy sessions
Intervention Type
Other
Intervention Name(s)
Standard care
Intervention Description
Patient undergoing radiotherapy for head and neck tumor with a compression mask, and assessed as anxious about wearing this mask will have standard care
Intervention Type
Other
Intervention Name(s)
Autohypnosis
Intervention Description
The patient will be called to learn autohypnosis during a specific consultation, with a radiotherapy manipulator trained to learn this technic. The patient will use this technic during the centering scanner and the first 5 radiotherapy sessions
Intervention Type
Other
Intervention Name(s)
Musicotherapy
Intervention Description
the patient will choose the music he want to listen from a music database (3 specific moods). The chosen music will be broadcast to the patient via a hi-fi system present in the treatment room during the centering scanner and for the first 5 radiotherapy sessions
Primary Outcome Measure Information:
Title
Anxiety
Description
Anxiety will be assessed by the maximum value obtained on the STAI form Y-A questionnaire (state anxiety) on the following 3 measurements: on the centering scanner, at the first and 5th radiotherapy session.
Time Frame
5 weeks
Secondary Outcome Measure Information:
Title
Anxiety
Description
Anxiety will also be assessed by a digital rating scale (0 to 10), in the centering or radiotherapy scanner room, just before making the mask before the centering scan and before fitting the mask before each of the first five radiotherapy sessions
Time Frame
5 weeks
Title
Conduct of radiotherapy session
Description
The good conduct of the centering scanner and radiotherapy session is determined by: no interruption of the session the absence of vocal intervention by the manipulator during the session
Time Frame
5 weeks
Title
Time required by the hypnopractor for the hypnosis session
Description
The duration of the conditioning hypnosis session will be collected by the hypnopractor manipulator
Time Frame
1 hour
Title
Receptivity of patients to hypnosis
Description
Corresponds to the time difference in minutes between the actual time of making and wearing the compression mask for the centering scanner and wearing a compression mask for the first 5 radiotherapy sessions and the time estimated by the patient
Time Frame
5 weeks
Title
Assessment of the patient's feelings
Description
The patient's feelings will be evaluate a questionnaire composed of 5 questions already used in a previous study
Time Frame
1 hour
Title
Hypnopractic manipulator's satisfaction with the ease of performing the conditioning hypnosis
Description
Assesing by the hypnopractor manipulator at the end of the session using a digital rating scale (0 to 10).
Time Frame
1 hour

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age > or =18 Patient to receive radiotherapy for a tumor of the head and neck, with a compression mask Patient who obtained a score equal to or greater than 56 on the STAI form Y-A questionnaire during the consultation with the radiotherapist before starting treatment Patient capable and willing to follow all study procedures in accordance with the protocol Patient who understood the study and gave informed consent Patient affiliated to a social security system Exclusion Criteria: Contraindication to hypnosis: psychosis, schizophrenia Non-French speaking patient Significant hearing loss Pregnant woman, likely to be, or breastfeeding Persons deprived of their liberty or under guardianship (including guardianship) Inability to undergo medical monitoring of the trial for geographical, social or psychological reasons Patient who has already received radiotherapy to the head or neck with a compression mask
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Jean Louis MERLIN, PU PH
Phone
+33 (0)3 83 65 60 62
Email
jl.merlin@nancy.unicancer.fr
First Name & Middle Initial & Last Name or Official Title & Degree
Marie-Aude HERMAN
Phone
+33 (0)3 83 53 86 68
Email
m.herman@nancy.unicancer.fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Rémi ETIENNE
Organizational Affiliation
Institut de Cancérologie de Lorraine
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
RENARD Sophie, MD
Organizational Affiliation
Institut de Cancérologie de Lorraine
Official's Role
Principal Investigator
Facility Information:
Facility Name
Institut de Cancérologie de Lorraine
City
Vandoeuvre les nancy
ZIP/Postal Code
54519
Country
France
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Sophie RENARD, MD
Phone
+33 (0)3 83 59 85 34
Email
s.renard@nancy.unicancer.fr
First Name & Middle Initial & Last Name & Degree
Rémi ETIENNE
Phone
+33 (0)3 83 59 40 07
Email
r.etienne@nancy.unicancer.fr
First Name & Middle Initial & Last Name & Degree
Jean-Christophe Faivre, MD
First Name & Middle Initial & Last Name & Degree
Paul Jung, MD
First Name & Middle Initial & Last Name & Degree
Anaïs Stéfani, MD
First Name & Middle Initial & Last Name & Degree
Maria Jolnerovski, MD
Facility Name
Institut de Cancérologie de Lorraine
City
Vandœuvre-lès-Nancy
ZIP/Postal Code
Vandoeuvre lès Nancy
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Sophie RENARD, MD
Phone
038359427
Ext
0033
Email
s.renard@nancy.unicancer.fr

12. IPD Sharing Statement

Learn more about this trial

Effectiveness of autoHYpnosis in the Prevention of Anxiety During Radiotherapy of Head and Neck Tumors (HYMACO)

We'll reach out to this number within 24 hrs